Nuvalent Appoints New Director to Board
Ticker: NUVL · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1861560
Sentiment: neutral
Topics: board-appointment, governance
Related Tickers: NUVAL
TL;DR
Nuvalent adds Dr. R. Brad Evans to its board as a Class II Director.
AI Summary
Nuvalent, Inc. announced on June 18, 2025, a change in its board of directors. Specifically, Dr. R. Brad Evans has been appointed as a Class II Director, effective immediately. This appointment is part of the company's ongoing governance and strategic direction.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.
Risk Assessment
Risk Level: low — The filing reports a routine board appointment, which typically carries low inherent risk.
Key Players & Entities
- Nuvalent, Inc. (company) — Registrant
- Dr. R. Brad Evans (person) — Appointed Class II Director
- June 18, 2025 (date) — Effective date of appointment
FAQ
Who has been appointed as a Class II Director at Nuvalent, Inc.?
Dr. R. Brad Evans has been appointed as a Class II Director.
When was the appointment of Dr. R. Brad Evans effective?
The appointment was effective as of June 18, 2025.
What is the exact name of the registrant filing this report?
The exact name of the registrant is Nuvalent, Inc.
In which state was Nuvalent, Inc. incorporated?
Nuvalent, Inc. was incorporated in Delaware.
What is the business address of Nuvalent, Inc.?
The business address is One Broadway, 14th Floor, Cambridge, Massachusetts 02142.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 by Dr. R. Brad Evans regarding Nuvalent, Inc. (NUVL).